5% stakes
Commodore Capital
Institution
- 5% stake reports
- 47
- 5% stake stocks
- 31
- Latest report
- 26/09/02
5% stake reports
| Stock | ||
|---|---|---|
| Jatt III Acquisition JTTT09/02 | 5.2%400,000 sh | First report |
| InflaRx IFRX08/17 | 5.1%7,475,000 sh | First report |
| Palisade Bio PALI08/14 | 0%0 sh | −7.2pp |
| Jatt II Acquisition JATT08/14 | 0%0 sh | −6.4pp |
| Relay Therapeutics RLAY08/14 | 5.5%12,000,000 sh | −4.4pp |
| Definium Therapeutics DFTX08/14 | 1.8%2,410,000 sh | −5.4pp |
| Research Alliance Corp IV RACD07/20 | 5.5%500,000 sh | First report |
| Avalo Therapeutics AVTX06/18 | 9.9%5,721,109 sh | First report |
| EyePoint EYPT06/03 | 5.1%4,250,000 sh | First report |
| Editas Medicine EDIT06/02 | 9.9%16,045,802 sh | First report |
| Research Alliance Corp III RACC05/28 | 5.5%500,000 sh | First report |
| Enliven Therapeutics ELVN05/15 | 7.7%4,800,940 sh | −2.2pp |
| PepGen PEPG05/15 | 6.5%4,475,000 sh | +1.4pp |
| Tyra Biosciences TYRA05/15 | 4.2%2,475,000 sh | −2.1pp |
| Palisade Bio PALI05/15 | 7.2%12,366,776 sh | −2.7pp |
| LB Pharmaceuticals LBRX05/15 | 6.8%1,972,369 sh | +1.3pp |
| Relmada Therapeutics RLMD05/04 | 5.1%5,505,527 sh | First report |
| Jatt II Acquisition JATT04/24 | 6.4%500,000 sh | First report |
| Karyopharm Therapeutics KPTI04/02 | 9.9%1,950,000 sh | First report |
| AN2 Therapeutics ANTX03/16 | 9.9%3,697,435 sh | First report |
